Cargando…
Characteristics of Seltorexant—Innovative Agent Targeting Orexin System for the Treatment of Depression and Anxiety
Twenty-five years have passed since the discovery of the orexin system, during which time we have learned more and more about it. A number of studies have been conducted showing the role of the orexin system in insomnia, as well as its potential use in the treatment of obesity and depression. In thi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142100/ https://www.ncbi.nlm.nih.gov/pubmed/37110810 http://dx.doi.org/10.3390/molecules28083575 |
_version_ | 1785033533404741632 |
---|---|
author | Ziemichód, Wojciech Kurowska, Antonina Grabowska, Karolina Kurowska, Michalina Biała, Grażyna |
author_facet | Ziemichód, Wojciech Kurowska, Antonina Grabowska, Karolina Kurowska, Michalina Biała, Grażyna |
author_sort | Ziemichód, Wojciech |
collection | PubMed |
description | Twenty-five years have passed since the discovery of the orexin system, during which time we have learned more and more about it. A number of studies have been conducted showing the role of the orexin system in insomnia, as well as its potential use in the treatment of obesity and depression. In this review, we present the role of the orexin system in the development of depressive illness and show the characteristics of seltorexant, a potential drug for the treatment of depression. This review describes the structure and synthesis of the compound as well as its pharmacodynamics and pharmacokinetics. Pre-clinical and clinical studies are also described, including side effects. There is evidence that the use of seltorexant is considered safe, with no clear or major clinically significant side effects, which makes it a promising candidate for the treatment of depression and anxiety disorders. |
format | Online Article Text |
id | pubmed-10142100 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101421002023-04-29 Characteristics of Seltorexant—Innovative Agent Targeting Orexin System for the Treatment of Depression and Anxiety Ziemichód, Wojciech Kurowska, Antonina Grabowska, Karolina Kurowska, Michalina Biała, Grażyna Molecules Review Twenty-five years have passed since the discovery of the orexin system, during which time we have learned more and more about it. A number of studies have been conducted showing the role of the orexin system in insomnia, as well as its potential use in the treatment of obesity and depression. In this review, we present the role of the orexin system in the development of depressive illness and show the characteristics of seltorexant, a potential drug for the treatment of depression. This review describes the structure and synthesis of the compound as well as its pharmacodynamics and pharmacokinetics. Pre-clinical and clinical studies are also described, including side effects. There is evidence that the use of seltorexant is considered safe, with no clear or major clinically significant side effects, which makes it a promising candidate for the treatment of depression and anxiety disorders. MDPI 2023-04-19 /pmc/articles/PMC10142100/ /pubmed/37110810 http://dx.doi.org/10.3390/molecules28083575 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ziemichód, Wojciech Kurowska, Antonina Grabowska, Karolina Kurowska, Michalina Biała, Grażyna Characteristics of Seltorexant—Innovative Agent Targeting Orexin System for the Treatment of Depression and Anxiety |
title | Characteristics of Seltorexant—Innovative Agent Targeting Orexin System for the Treatment of Depression and Anxiety |
title_full | Characteristics of Seltorexant—Innovative Agent Targeting Orexin System for the Treatment of Depression and Anxiety |
title_fullStr | Characteristics of Seltorexant—Innovative Agent Targeting Orexin System for the Treatment of Depression and Anxiety |
title_full_unstemmed | Characteristics of Seltorexant—Innovative Agent Targeting Orexin System for the Treatment of Depression and Anxiety |
title_short | Characteristics of Seltorexant—Innovative Agent Targeting Orexin System for the Treatment of Depression and Anxiety |
title_sort | characteristics of seltorexant—innovative agent targeting orexin system for the treatment of depression and anxiety |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142100/ https://www.ncbi.nlm.nih.gov/pubmed/37110810 http://dx.doi.org/10.3390/molecules28083575 |
work_keys_str_mv | AT ziemichodwojciech characteristicsofseltorexantinnovativeagenttargetingorexinsystemforthetreatmentofdepressionandanxiety AT kurowskaantonina characteristicsofseltorexantinnovativeagenttargetingorexinsystemforthetreatmentofdepressionandanxiety AT grabowskakarolina characteristicsofseltorexantinnovativeagenttargetingorexinsystemforthetreatmentofdepressionandanxiety AT kurowskamichalina characteristicsofseltorexantinnovativeagenttargetingorexinsystemforthetreatmentofdepressionandanxiety AT białagrazyna characteristicsofseltorexantinnovativeagenttargetingorexinsystemforthetreatmentofdepressionandanxiety |